Coagulation and fibrinolysis in children with acute lymphoblastic leukaemia treated according to the COALL-05-92-protocol

Klinische Padiatrie

Volumn 210, Issue 4, 1998, Pages 285-290

  Kirschke, Ralf ^a   Nürnberger, Wenzel ^a   Eckhof Donovan, Susanne ^a   Nürnberger, Iris ^a   Göbel, Ulrich ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Acute lymphoblastic leukaemia in children; Asparaginase; Fibrinolysis; Methotrexate; Plasminogen

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIPLASMIN; ANTITHROMBIN; ARABINOSIDE; ASPARAGINASE; CYCLOPHOSPHAMIDE; METHOTREXATE; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLOOD CLOTTING; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL PROTOCOL; FEMALE; FIBRINOLYSIS; HUMAN; INDWELLING CATHETER; MALE; THROMBOEMBOLISM;

EID: 0031877158     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043893     Document Type: Article

References (39)

1. Amiral, J., A. M. Vissa, F. Mimilla, B. Grosley: Assay of blood activation by measurement of AT III-serine esterase complexes (ATM) using a specific monoclonal antibody 4C9. Thromb. Haemostas. 62 (1989) 479
2. Aschka, I., V. Aumann, F. Bergmann, U. Budde, W. Eberl, S. Eckhof-Donovan, S. Krey, V. Nowak-Göttl, R. Schobess, A. H. Sutor, J. Wendisch, R. Schneppenheim: Prevalence of factor V Leiden in children with thrombo-embolism. Eur. J. Pediatr. 155 (1996) 1009-1014
3. Asselin, B. L., J. C. Whitin, D. J. Coppola, I. P. Rupp, S. E. Sallan, H. J. Cohen: Comparative pharmacokinetic studies of three asparaginase preparations. J. Clin. Oncol. 11 (1993) 1780-1786
4. Barthels, M., H. Poliwoda: Gerinnungsanalysen. 5. Auflage (1997) Thieme Verlag
5. Capizzi, K. L., J. S. Holcenberg: Asparaginase. In: Holland, J. F., E. Frei, K. C. Bast, D. W. Kufe, D. L. Morton, R. R. Weichselbaum: Cancer Medicine. Lea & Febiger (1993) 796-803
6. Clavell, L. A., R. D. Gelber, H. J. Hohen, S. Hitchcock-Bryan, J. Cassady, N. J. Tarbell, S. R. Blattner, R. Tantravahi, P. Leavitt, S. E. Sallan: Fouragent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukaemia. N. Engl. J. Med. 315 (1986) 657-663
7. Delmonte, L., T. H. Jukes: Folic acid antagonist in cancer chemotherapy. Pharmacol. Rev. 14 (1962) 91-135
8. Eckhof-Donovan, S., D. Schwamborn, D. Körholz, I. Michelmann, R. v. Kries, W. Nürnberger, U. Göbel: Thromboses in children with acute lymphoblastic leukaemia treated by the COALL-protokol. Klin. Pädiatric 206 (1994) 327-330
9. Gadner, H., H. Riehm: Veränderungen der Hämostase während der Induktionstherapie akuter lymphoblstischer Leukämien im Kindesalter. In: Göbel U. (Hrsg.): Erworbene Gerinnungsstörungen im Kindesalter. 130-139 (1977) Enke Verlag
10. Gram, J., J. Jespersen: A functional plasminogen assay utilizing the potential effect of fibrinogen to correct for the overestimation of plasminogen in pathological plasma samples. Thromb. Haemostas. 53 (1985) 255-259
11. Haskell, C. M., G. P. Cuneellos, B. C. Leventhal, P. P. Carbone, J. B. Block, A. A. Serpick, O. S. Selewry: L-asparaginase: Therapeutic and toxic effects in patients with neoplastic disease. Eng. J. Med. 281 (1969) 1028-1034
12. Humphries, S. E., A. Panahloo, H. E. Montgomery, F. Green, J. Yudkin: Gene - environment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis. Thromb. Haemostas. 78 (1997) 457-461
13. Janka-Schaub, G., D. Harms, U. Göbel, U. Graubner, P. Gutjahr, R. J. Haas, H. Jürgens, H. J. Spaar, K. Winkler: Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood - follow up after 9 years. Eur. J. Pediatr. 155 (1996) 640-648
14. Jürgens, H., W. Ebell, R. Bachmann, I. Kupke, O. Richter, A. Andras, U. Göbel: Essential laboratory determination for monitoring high-dose methotrexate treatment with citrovorum factor rescue. Pediatr. Pharmacol. 3 (1983) 157-165
15. Kang, S. S., J. Zhou, P. W. K. Wong, J. Kowalisyn, G. Strokosch: Intermediate homocysteinemia: A thermolabile variant of methylletrahydrofolate reductase. Am. J. Hum. Genet. 43 (1988) 414-421
16. Leone, G., L. Gugliotta, M. G. Mazzuccioni, V. de Stefano: Evidence of a hypercoagulable state in patients with ALL treated with low dose of E. coli L-Asparaginase - A GIMEMA Study. Thromb. Haemostas. 69 (1993) 12-15
17. Martinelli, I., E. Sacchi, G. Laudi, E. Taioli, F. Duca, P. Mannuccio Mannucci: High risk of cerebral vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N. Engl. J. Med. 338 (1998) 1793-1797
18. Mitchell, L., H. Hoogendoorn, A. R. Giles, P. Vegh, M. Andrews: Increased endogenous thrombin generation in children with ALL: Risk of thrombotic complications in L-asparaginase-induced antithrombin III deficiency. Blood 83 (1994) 386-391
19. Mitchell, L. G., A. H. Sutor, M. Andrew: Hemostasis in childhood acute lymphoblastic leukaemia: Coagulopathy induced by disease and treatment. Sem. Thromb. Hemostas. 21 (1995) 390-401
20. Nowak-Göttl, U., N. Kuhn, J. E. A. Wolff, J. Boos, B. Kehrel, B. Rath, H. Jürgens: Inhibition of hypercoagulation by antithrombin substitution in E. coli L-asparaginase-treated children. Eur. J. Haematol. 56 (1996a) 35-38
21. Nowak-Göttl, U., H. G. Koch, I. Aschka, K. Kohlhase, H. Vielhaber, G. Kurlemann, K. Oleszcuk-Raschke, H. G. Kehl, H. Jürgens, R. Schneppenheim: Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br. J. Haematol. 92 (1996b) 992-998
22. Nowak-Göttl, U., R. Schneppenheim, H. Vielhaber: APC resistance in childhood thromboembolism: diagnosis and clinical aspects. Semin. Thromb. Hemostas. 23 (1997) 253-258
23. Nürnberger, W., H. Kruck, C. Mauz-Körholz, St. Burdach, U. Göbel: Humoral coagulation and early complications after allogeniec bone marrow transplantation. Klin. Pädiatr. 209 (1997) 209-215
24. Nürnberger, W., I. Michelmann, St. Burdach, U. Göbel: Endothelial dysfunction after bone marrow transplantation: Increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant related complications. Ann. Hematol. (1998) (in press)
25. Oettgen, H. F., P. A. Stepenson, M. K. Schwartz, R. D. Leeper, L. Tallal, C. C. Tan, B. B. Clarkson, R. B. Globey, I. H. Krakoff, D. A. Karnofsky, M. L. Murphy, J. H. Burchenal: Toxicity of E. coli L-asparaginase in man. Cancer 25 (1970) 253
26. Pelzer, H., A. Schwarz, W. Stüber: Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide. Thromb. Haemostas. 65 (1991) 153-159
27. Pelzer, H., A. Schwarz, N. Heimburger: Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb. Haemostas. 59 (1988) 101-106
28. Priest, J. R., N. K. C. Ramsay, A. J. Bennett, W. Krivit, J. R. Edson: The effect of L-Asparaginase on antithrombin, plaminogen and coagulation during therapy for acute lymphoblastic leukaemia. J. Pediatr. 100 (1982) 990-995
29. Raum, D., D. Marcus, C. A. Alper, R. Levey, P. D. Taylor, T. E. Starzl: Synthesis of human plasminogen in the liver. Science 208 (1980) 1036-1037
30. Risseeuw-Appel, I. M., I. Dekker, W. C. J. Hop, K. Hählen: Minimal effects of E. coli and Erwinia Asparaginase on the coagulation system in childhood acute lymphoblastic leukaemia: A randomized study. Med. Fed. Oncol. 23 (1994) 335-343
31. Saito, M., H. Asakura, H. Jokaji, C. Uotani, I. Kumabashiiri, K. Ito, T. Matsuda: Changes in hemostatic and fibrinolytic proteins in patients receiving L-Asparaginase therapy. Amer. J. Hematol. 32 (1989) 20-23
32. Schieffer, M., D. Schwamborn, R. von Kries, U. Göbel: Structure and concentration of fibronectin in children with acute lymphoblastic leukaemia. In Wenzel, E. et al.: Rationelle Therapie und Diagnose von hämorrhagischen und thrombophilen Diathesen, Schattauer Verlag, 29, Tagung der Deutschen Arbeitsgemeinschaft für Blutgerinnungsforschung, Februar 1985
33. Schrappe, M., A. Reiter, S. Sauter, W.-D. Ludwig, B. Wörmann, J. Harbott, C. Bender-Götze, W. Döpfer, R. Dopfer, E. Frey, W. Havers, G. Henze, J. Kühl, R. Richter, J. Ritter, J. Treuner, F. Zintl, E. Odenwald, K. Welte, H. Riehm: Conception and interim analysis of trial ALL-BFM 90 for the treatment of children and adolescents with acute lymphoblastic leukaemia: significance of therapy response in peripheral blood and bone marrow. Klin. Padiatr. 206 (1994) 208-221
34. Semeraro, N., P. Montemuro, P. Giordano, F. Schettini, N. Santoro, D. De Mattia, D. Giordano, M. Conese, M. Colucci: Unbalanced coagulation-fibrinolysis potential during L-asparaginase therapy in children with acute lymphoblastic leukaemia. Thromb. Haemostas. 64 (1990) 38-40
35. Sutor, A. H., C. Niemeyer, S. Sauter, I. Witt, K. Kaufmehl, A. Rombach, M. Brandis, H. Riehm: Alteration of hemostasis with the treatment protocols ALL-FM-90 and NHL-BFM-90. Klin. Padiatr. 204 (1992) 264-273
36. Teger-Nilsson, A. C., P. Friberger, E. Gyzander: Determination of a rapid plasmin inhibitor in human blood by means of a plasmin specified tripeptide substrate. Scand. J. clin. Invest. 37 (1977) 403-409
37. Vogler, W. R., Z. H. Israili, A.-G. M. Soliman, S. Moffitt, B. Barlogie: Marrow cell kinetics in patients treated with methotrexate. Cancer 47 (1981) 215-223
38. Whitecar, J. P., G. P. Bodey, C. S. Hill, N. A. Samaan: Effect of L-asparaginase on carbohydrate metabolism. Metabolism 19 (1970) 581-586
39. Wieczorek, I., C. A. Ludlam, I. MacGregor: Venous occlusion does not release von Willebrand factor, factor VIII or PAI-1 from endothelial cells - The importance of consensus on the correction factors for haemoconcentration. Thromb. Haemostas. 69 (1993) 91-92